Cellectar Biosciences, Inc. (CLRB)
2.97
+0.02
(+0.68%)
USD |
NASDAQ |
Mar 26, 12:42
Cellectar Biosciences Free Cash Flow : -23.12M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| EyePoint Plc | -243.39M |
| Ocugen, Inc. | -57.15M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -101.06M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.344M |
| Cash from Investing (Quarterly) | -0.0059M |
| Cash from Financing (Quarterly) | 4.992M |
| Free Cash Flow Per Share (Quarterly) | -1.026 |
| Free Cash Flow to Equity (Quarterly) | -4.328M |
| Free Cash Flow to Firm (Quarterly) | -4.35M |
| Free Cash Flow Yield | -56.53% |